• Return to Headlines

Uptrend Call Working As Epizyme Inc Stock Rises 25.1% (EPZM)

By James Quinn

SmarTrend identified an Uptrend for Epizyme Inc (NYSE:EPZM) on August 8th, 2017 at $13.87. In approximately 4 weeks, Epizyme Inc has returned 25.14% as of today's recent price of $17.35.

In the past 52 weeks, shares of Epizyme Inc have traded between a low of $7.02 and a high of $18.50 and are now at $17.35, which is 147% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.4% while the 200-day MA has slid 1.9%.

Epizyme, Inc. develops and discovers therapeutics for the treatment of cancer. The Company provides small molecule inhibitors for patients with genetically defined cancers and inflammatory, metabolic, and neurodegenerative diseases. Epizyme operates in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Epizyme Inc shares.

Log in and add Epizyme Inc (EPZM) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights epizyme inc

Ticker(s): EPZM